In the News

Epigenetics Research Prompts Hope for Improved Treatment of Acute Myeloid Leukemia

Published on December 12, 2014

Dr. Roboz discusses the introduction of epigenetic and personalized therapies targeting acute myeloid leukemia (AML) at the American Society of Hematology’s Annual Meeting and Exposition. Click here to view the video.

 

Dr. Gail Roboz on Improving the Standard Treatment of AML

Published on November 27, 2012

Dr. Roboz explains the need for improving the standard treatment of acute myeloid leukemia (AML). The current treatment for AML (cytarbine and an anthracycline) has not changed much in the past 30 years and has poor success rates for patients older than 60. The standard 7 + 3 regimen is being analyzed for improvement by adding novel agents.

 

Good Morning America: Robin Roberts, Sister-Sally Ann and Doctor on MDS Battle

Published on August 30, 2012

Robin talks with her sister, Sally-Ann, and Dr. Roboz about her treatment for myelodysplastic syndrome (MDS).

 

Viewpoint on Community Oncology Clinical Debates: Chronic Myelogenous Leukemia (Part 1)

Published on July 9, 2012

This video roundtable discussion brings together a panel of expert leaders to address the latest clinical updates on the treatment of patients with chronic myelogenous leukemia (CML) in the frontline and relapsed settings.

 

Viewpoint on Community Oncology Clinical Debates: Chronic Myelogenous Leukemia (Part 2)

Published on July 9, 2012

This video roundtable discussion brings together a panel of expert leaders to address the latest clinical updates on the treatment of patients with chronic myelogenous leukemia (CML) in the frontline and relapsed settings.

 

Weill Cornell Medical College Selected to Join New MDS Clinical Research Consortium

Published on June 15, 2012

Weill Cornell Medical College is one of six institutions selected to join the new national MDS Clinical Research Consortium. Dr. Roboz, director of the Leukemia Program, describes what myelodysplastic syndrome (MDS) is and the Consortium’s mission.

 

Evolving Data Reported at ASH 2011 on the Treatment of Acute and Chronic Leukemias

Published on June 11, 2012

Dr. Roboz reviews the most clinically significant abstracts presented at ASH 2011 and provides commentary on the practice implications of the new data.

 

Positioning Hypomethylating Agents and “The Pipeline Ahead”

Published on November 3, 2011

Dr. Roboz discusses the future of treatment using hypomethylating agents to treat myelodysplastic syndrome (MDS). Click here to view the video.

 

The Inside Story: New Understanding and Treatments for Leukemia

Published on April 28, 2011

Dr. Roboz explains current and future directions of therapies for hard-to-treat leukemias.

 

2009 Annual Hematology Meeting: Best of the Day

Published December 8, 2009

Dr. Roboz discusses various trials available for myelodysplastic syndrome (MDS) patients.

http://oncologytube.com/embed.php?vid_id=100098

 

Genomic Study of Acute Myeloid Leukemia

Dr. Roboz talks with ecancer.tv at ASH 2011 in San Diego about the major genomic research on acute myeloid leukemia (AML). There has been a lot of recent success on identifying mutations and abnormalities in AML; however, Dr. Roboz believes that the discovery period with genomic research is coming to an end and a move towards clinical trials and targeted therapies need to be developed. The largest development has been the role of stems cell in research and how to target the cells that are left over after chemotherapy. Click here to view the video.

 

Robin Roberts Prepares for Bone Marrow Transplant

Dr. Roboz speaks about Robin Roberts and her preparation for a bone marrow transplant to treat her recently diagnosed myelodysplastic syndrome (MDS). Click here to view the video.